Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Transmembrane Transporters >  Potassium Channel Inhibitors >  DRONEDARONE HYDROCHLORIDE

DRONEDARONE HYDROCHLORIDE

Basic information Safety Supplier Related

DRONEDARONE HYDROCHLORIDE Basic information

Product Name:
DRONEDARONE HYDROCHLORIDE
Synonyms:
  • Multaq
  • N-(2-butyl-3-{4-[3-(dibutylaMino)propoxy]benzoyl}-1-benzofuran-5-yl)MethanesulfonaMide hydrochloride (1:1)
  • N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-benzofuran-5-yl)methanesulfonamide hydrochlorid
  • Dronedarone Hydrocholoride
  • CS-132
  • Dronedarone hydrochloride, ≥98% (HPLC)
  • N-[2-butyl-3-[4-(3-dibutyl-aminopropoxy) benzoyl] methanesulfonamide hydrochloride
  • SR-33589B
CAS:
141625-93-6
MF:
C31H44N2O5S.ClH
MW:
593.224
EINECS:
630-355-2
Product Categories:
  • Amines
  • Aromatics
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • API
  • 141625-93-6
Mol File:
141625-93-6.mol
More
Less

DRONEDARONE HYDROCHLORIDE Chemical Properties

Melting point:
NA (low-melting)
storage temp. 
2-8°C
solubility 
DMSO: soluble15mg/mL, clear
form 
powder
color 
white to off-white
Merck 
14,3449
Stability:
Hygroscopic
InChIKey
DWKVCQXJYURSIQ-UHFFFAOYSA-N
More
Less

Safety Information

RIDADR 
UN 3077 9 / PGIII
WGK Germany 
3
HS Code 
2935904000
More
Less

DRONEDARONE HYDROCHLORIDE Usage And Synthesis

Chemical Properties

Pale Yellow Solid

Uses

Cardiovascular Drugs

Uses

Dronedarone Hydrochloride can be used for the treatment of atrial fibrillation and atrial flutter in patients who have suffered cardiac arrhythmias.

Uses

Dronedarone Hydrochloride is a therapy for the treatment of patients with paroxysmal and persistent atrial fibrillation or atrial flutter.

Biological Activity

dronedarone hcl is an amiodarone analogue which has been shown an effective and promising treatment for atrial fibrillation (af) [1].

Biochem/physiol Actions

Dronedarone is a Class III antiarrhythmic and a multi-channel blocker for atrial fibrillation. It blocks potassium, sodium, and calcium channels and also exhibits antiadrenergic properties.

Clinical Use

Dronedarone hydrochloride (also known as SR33589 and marketed as Multaq) is a drug developed by Sanofi-Aventis for cardiac arrhythmias (irregular heartbeat) that was approved by the FDA in July 2009. Dronedarone is used for the treatment of atrial fibrillation and atrial flutter in patients whose hearts have either returned to normal rhythm or who undergo drug therapy or electroshock treatment to maintain normal cardio rhythm. Dronedarone is less lipophilic than amiodarone, exhibits a much smaller volume of distribution and a half-life of 24 h, this stands in contrast to competitor amiodarone’s half-life of several weeks. As a result of these pharmacokinetic characteristics, dronedarone dosing may be less complicated than amiodarone.

Synthesis

The synthesis of dronedarone relies on the preparation of the benzofuran core 34, of which three main routes have been reported, but two possess obvious overlap and are considered more process-amenable. Starting from methyl 2-(2-formylphenoxy)hexanoate (32), this aldehyde can either be nitrated, then saponified or saponified and then nitrated to procure nitroacid 33 (the Scheme). The benzofuran ring is then secured through the use of acetic anhydride and base in the presence of DMF at elevated temperature. The key benzofuran 34 can be produced by either route in 62% yield on gramscale by this method. Friedel¨CCrafts acylation involving anisoyl chloride and tin tetrachloride constructed the diaryl ketone 35. Cleavage of the methyl ether through the use of aluminum trichloride in refluxing DCE provided phenol 36. Alkylation of phenol 36 with aminoalkyl chloride 37 gave ether 38. Subsequent reduction of the nitro group via catalytic hydrogenation and sulfonylation of the resulting amine provided dronedarone (VII) which was isolated as its HCl salt.

in vitro

dronedarone has been demonstrated to inhibit muscarinic acetylcholine receptor-operated k+ current ik(ach) induced by carbachol or gtp-gamma-s with ic50 values of 10nm and <100nm, respectively, in cells isolated from guinea pig atria. notably, dronedarone was 100-fold potent and selective over amiodarone in inhibiting ik(ach) [1].

in vivo

dronedarone has shown to block arterial thrombus formation, decrease platelet aggregation and reduce plasminogen activator inhibitor-1 (pai1) expression in c57bl/6 mice [2].

References

[1] guillemare e1, marion a, nisato d, gautier p. inhibitory effects of dronedarone on muscarinic k+ current in guinea pig atrial cells. j cardiovasc pharmacol. 2000 dec;36(6):802-5.
[2] breitenstein a1, sluka sh, akhmedov a, stivala s, steffel j, camici gg, riem hh, beer hj, studt jd, duru f, luscher tf, tanner fc. dronedarone reduces arterial thrombus formation. basic res cardiol. 2012 nov;107(6):302.

DRONEDARONE HYDROCHLORIDESupplier

Allikang Pharmaceutical Co., LTD Gold
Tel
0573-87390950 13806705416
Email
wzj@alicornpharma.com
Shandong Fuchuang Pharmaceutical Technology Co. , Ltd. Gold
Tel
0531-88792816 18615587029
Email
fcpharm2006@126.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Chembest Research Laboratories Limited
Tel
021-20908456
Email
sales@BioChemBest.com
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com